Syndax Pharmaceuticals (SNDX) Earnings
|
Expand Research on SNDX
| Next EPS Date | 5/6/24 | EPS Growth Rate | -61.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +6.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -4.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/6/24 | Q124 | N/A | -$0.95 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/27/24 | Q423 | -$1.00 | -$0.97 | -$0.03 | N/A | N/A | N/A |  | | Details | |
| 11/2/23 | Q323 | -$0.73 | -$0.79 | +$0.06 | N/A | N/A | N/A | | | Details | |
| 8/3/23 | Q223 | -$0.64 | -$0.72 | +$0.08 | N/A | N/A | N/A | | | Details | |
| 5/8/23 | Q123 | -$0.59 | -$0.65 | +$0.06 | N/A | $800K | N/A | | | Details | |
| 2/28/23 | Q422 | -$0.62 | -$0.65 | +$0.03 | N/A | $1.6M | N/A | | | Details | |
| 11/3/22 | Q322 | -$0.40 | -$0.67 | +$0.27 | $12.38M | $1.5M | N/A | | | Details | |
| 8/8/22 | Q222 | -$0.44 | -$0.64 | +$0.20 | $379K | $1.83M | N/A | | | Details |
